Table 1.

Clinical characteristics for three groups: Initial patients treated at Duke (1991-1999) and the two newer groups from Duke (1999-2005), and the NKI (1996-2002)

Characteristics	Duke (%) (n=55) 1999-2005	NKI (%) (n=65) 1996-2002	Duke (%) (n=62) 1991-1999
Mean age (range)	64 (46-81)	72 (48-86)	62 (40-87)
Gender (female/male)	23/32	15/50	26/36
Histology
Non-small cell	45 (82)	65 (100)	57 (92)
Small cell	10 (18)	-	5 (8)
Stage
I-II	2 (4)	28 (43)	16 (26)
III-IV	48 (87)	37 (57)	41 (66)
Recurrent	5 (9)	-	5 (8)
Predicted baseline PFTs, %
Mean FEV1 (range)	68 (21-127)	63 (17-121)	62 (17-121)
Mean DLCO (range)	74 (28-129)	70 (20-128)	65 (23-114)